Treatment of Hairy Cell Leukaemia with 2′-Deoxycoformycin

References

• Bouroncle B. A., Wiseman B. K., Doan C. A. Leukemic reticuloendotheliosis. Blood 1958; 13: 609–30
   PubMed Web of Science ®Google Scholar
• Jansen J., Hermans J. For the collaborative study group. Splenectomy in hairy cell leukemia. A retrospective multi-center analysis. Cancer 1981; 47: 2066–76
   PubMed Web of Science ®Google Scholar
• Golomb H. M., Mintz U. Treatment of hairy cell leukemia (leukemic reticuloendotheliosis). II. Chlorambucil therapy in postsplenectomy patients with progressive disease. Blood 1979; 54: 305–9
   PubMed Web of Science ®Google Scholar
• Cold S., Brincker H. Chemotherapy of progressive hairy cell leukaemia. European Journal of Haematology 1987; 38: 251–5
   PubMed Web of Science ®Google Scholar
• Quesada J. R., Hersh E. M., Manning J. Treatment of hairy cell leukemia with recombinant a-Interferon. Blood 1986; 68: 493–7
   PubMed Web of Science ®Google Scholar
• Golomb H. M., Jacobs A., Fefer A. Alpha-2 Interferon therapy of hairy cell leukaemia: a multicenter study of 64 patients. Journal of Clinical Oncology 1986; 4: 900–5
   PubMed Web of Science ®Google Scholar
• Worman C. P., Catovsky D., Cawley J. C. The UK experience with human lymphoblastoid interferon in HCL: a report of the first 50 cases. Leukemia 1987; 1: 320–2
   PubMed Web of Science ®Google Scholar
• Quesada J. R., Lepe-Zuniga J. L., Gutterman J. U. Mid-term observations on the efficacy of α-interferon in hairy cell leukemia and status of the interferon system of patients in remission. Leukemia 1987; 1: 317–9
   PubMed Web of Science ®Google Scholar
• Johnston J. B., Glazer R. I., Pugh L., Israels L. G. The treatment of hairy-cell leukaemia with 2′-deoxycoformycin. British Journal of Haematology 1986; 63: 525–34
   PubMed Web of Science ®Google Scholar
• Foon K. A., Nakano G. M., Koller C. A., Longo D. L., Steis R. G. Response to 2′-deoxycoformycin after failure of interferon-cc in nonsplenectomised patients with hairy cell leukemia. Blood 1986; 68: 297–300
   PubMed Web of Science ®Google Scholar
• Kraut E. H., Bouroncle B. A., Grever M. R. Low-dose deoxycoformycin in the treatment of hairy cell leukemia. Blood 1986; 68: 1119–22
   PubMed Web of Science ®Google Scholar
• Spiers A. S. D., Moore D., Cassileth P. A. Remissions in hairy cell leukemia with pentostalin (2′-deoxyco-formycin). New England Journal of Medicine 1987; 316: 825–30
   PubMed Web of Science ®Google Scholar
• Ikartien C., Catovsky D. Current treatment of hairy cell leukaemia. European Journal of Haematology 1988; 41: 183–6
   Google Scholar
• Grem J. L., King S. A., Cheson B. D., Leyland-Jones B., Wittes R. E. Pentostatin in hairy cell leukemia: treatment by the special exception mechanism. Journal of the National Cancer Institute 1989; 81: 448–53
   PubMed Web of Science ®Google Scholar
• Smyth J. F., Paine R. M., Jackman A. L. The clinical pharmacology of the adenosine deaminase inhibitor 2-deoxycoformycin. Cancer Chemotherapy and Pharmacology 1980; 5: 93–101
   PubMed Web of Science ®Google Scholar
• Mitchell B. S., Edwards N. L., Koller C. A. Deoxyribonucleotide triphosphate accumulation by leukemic cells. Blood 1983; 62: 419–424
   PubMed Web of Science ®Google Scholar
• Grever M. R., Siaw M. F. E., Jacob W. F. The biochemical and clinical consequences of 2′-deoxycoformycin in refractory lymphoproliferative malignancy. Blood 1981; 57: 406–17
   PubMed Web of Science ®Google Scholar
• Ho A. D., Ganeshaguru K., Knauf W. U. Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells. in vivo. Blood 1988; 72: 1884–90
   PubMed Web of Science ®Google Scholar
• Siaw M. F. E., Mitchell B. S., Koller C. A., Coleman M. S., Hutton J. J. ATP depletion as a consequence of adenosine deaminase inhibition in man. Proceedings of the National Academy of Science, USA 1980; 77: 6157–6161
   PubMed Web of Science ®Google Scholar
• Matsumoto S. S., Yu J., Yu A. L. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes. Journal of Immunology 1983; 131: 2762–2766
   PubMed Web of Science ®Google Scholar
• Begleiter A., Glazer R. I., Israels L. G., Pugh L., Johnston J. H. Induction of DNA strand breaks in chronic lymphocytic leukemia following treatment with 2′-deoxycofor-mycin in vivo and. in vitro. Cancer Research 1987; 47: 2498–2503
   PubMed Web of Science ®Google Scholar
• Lamballe F., Le Prise P.-Y., Le Gall E., David J.-C. dATP-mediated inhibition of DNA ligase by 2′-deoxycoformycin in T and B cell leukemia. Leukemia 1989; 3: 97–103
   PubMed Web of Science ®Google Scholar
• Siaw M. F. E., Coleman M. S. In vitro metabolism of deoxycoformycin in human T lymphoblastoid cells. Journal of Bid Chem. 1984; 259: 9426
   PubMed Web of Science ®Google Scholar
• Seto S., Carrera C. J., Kubota M., Wasson W., Carson D. A. Mechanism of deoxyadenosine and 2′-chloratieoxya-denosine toxicity to non-dividing human lymphocytes. Journal of Clinical Investigation 1985; 75: 377–82
   PubMed Web of Science ®Google Scholar
• Dissing J., Knudsen B. Adenosine deaminase deficiency and combined immunodeficiency syndrome. Lancet 1972; ii: 1316
   Google Scholar
• Hoffbrand A. V., Ma D. D. F., Webster A. D. B. Enzyme patterns in normal lymphocyte subpopulations, lymphoid leukemias and immunodeficiency syndromes. Clinical Haematology 1982; 11: 719–741
   PubMedGoogle Scholar
• Smyth J., Poplack D. G., Holiman B. J., Leventhal B. G., Yarbro G. Correlation of adenosine deaminase activity with surface markers in acute lymphoblastic leukemia. Journal of Clinical Investigation 1978; 62: 710–712
   PubMed Web of Science ®Google Scholar
• Smyth J. F., Prentice H. G., Proctor S., Hoffbrand A. V. Deoxycoformycin in the treatment of leukemias and lymphomas. Annals of the New York Academy of Science 1986; 451: 123–8
   Web of Science ®Google Scholar
• O'Dwyer P. J., Wagner B., Leyland-Jones B. 2′-deoxycoformycin (Pentostatin) for lymphoid malignancies. Rational development of an active new drug. Annals of Internal Medicine 1988; 108: 733–743
   PubMed Web of Science ®Google Scholar
• Grever M. R., Leiby J. M., Kraut E. H. Low-dose deoxycoformycin in lymphoid malignancy. Journal of Clinical Oncoloyy 1985; 3: 1196–210
   PubMed Web of Science ®Google Scholar
• Matutes E., Worner I., Sainati L., De Oliveira M. P., Catovsky D. Advances in the lymphoproliferative disorders. Review of our experience in the study of over 1000 cases. Biol. Clin. Haematol. 1989; 11: 53–62
   Google Scholar
• O'Dwyer P. J., Spiers A. S. D., Marsoni S. Association of severe and fatal infections and treatment with Pentostatin. Cancer Treatment Reports 1986; 70: 1111–1120
   Google Scholar
• Urba W. J., Baseler M. W., Kopp W. C. Deoxycoformycin induced immunosuppression in patients with hairy cell leukemia. Blood 1989; 73: 38–46
   PubMed Web of Science ®Google Scholar